Immunotherapy By Cancer Type

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link
Impacting All Cancers

From the preventive vaccine for cervical cancer to the first therapy ever proven to extend the lives of patients with metastatic melanoma, immunology has already led to major treatment breakthroughs for a number of cancers. Every cancer type is unique, though, and immunology and immunotherapy are impacting each cancer in different ways.

Bladder Cancer
The first FDA-approved immunotherapy treatment—Bacillus Calmette-Guérin cancer vaccine—was for bladder cancer in 1990.
Brain Cancer
Malignant brain tumors are relatively rare but very serious form of cancer. Immunotherapy is showing significant promise where other approaches have failed.
Breast Cancer
Breast cancer is one of the most commonly diagnosed cancer types among women globally.
Cervical Cancer
By far, the most significant cause of cervical cancer, as well as other ano-genital cancers, is infection with a virus—the human papillomavirus (HPV).
Childhood Cancer
Cancer affects an estimated 300,000 young people every year. Immunotherapy has the potential to improve both their survival and quality of life.
Colorectal Cancer
Colorectal cancer is the third most common type of cancer among both men and women in the United States, and is the second most deadly.
Esophageal Cancer
There are two main types of esophageal cancer: squamous cell carcinoma and adenocarcinoma.
Head and Neck Cancer
While many different types of cancer can occur in the head and neck, squamous cell carcinoma in the most common cancer of the head and neck.
Kidney Cancer
About 9 out of every 10 kidney cancers are renal cell carcinomas—cancers that form in the lining of the tubules inside the kidney.
There are several FDA-approved immunotherapy treatments for leukemia (leukaemia) and ongoing research demonstrates even greater potential for new treatments.
Liver Cancer
When diagnosed early, liver cancer can be treated successfully with surgery, but liver donors are rare and few treatment options exist for patients with advanced disease.
Lung Cancer
Immunotherapy is a promising treatment option for advanced lung cancer, alone or in combination with conventional treatments like chemotherapy or surgery.
Lymphoma is the name for a group of blood cancers that develop in certain immune cells. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL).
Melanoma accounts for the majority of skin cancer-related deaths. Over the past few years, immunotherapy has dramatically changed the landscape of melanoma treatment.
Multiple Myeloma
Myeloma—also referred to as multiple myeloma or plasma cell myeloma—is a cancer that originates in plasma cells, a type of white blood cell that make antibodies.
Ovarian Cancer
Ovarian cancer often progresses before symptoms arise. Nine out of 10 ovarian cancers are epithelial, deriving from the outer layer of the ovary.
Pancreatic Cancer
Pancreatic cancer is the most lethal cancer, and new therapies are urgently needed to impact pancreatic cancer treatment and to extend and save pancreatic cancer patients’ lives.
Prostate Cancer
Prostate cancer is the second most common cancer in men worldwide, and the eighth leading cause of cancer-related death.
Sarcoma is a rare cancer in adults (1% of all adult cancers), but rather prevalent in children (about 15% of all childhood cancers).
Stomach Cancer
Stomach cancer is the fifth most common diagnosis in cancer, and it is the third most deadly, with nearly 725,000 deaths.

*Immunotherapy results may vary from patient to patient.